These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6437435)

  • 1. Topical immunotherapy for pseudomonas keratitis in rabbits: use of antilipopolysaccharide plasma.
    Welsh NH; Rauch AJ; Gaffin SL
    Br J Ophthalmol; 1984 Nov; 68(11):828-32. PubMed ID: 6437435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-pseudomonas activity of anti-lipopolysaccharide hyperimmune equine plasma.
    Wells M; Gaffin SL
    Clin Exp Immunol; 1987 Apr; 68(1):86-92. PubMed ID: 3115643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the (Fab')2 fragment of the anti-Pseudomonas aeruginosa antibodies on Pseudomonas-induced keratitis in rats].
    Ren PX
    Yan Ke Xue Bao; 1986 Dec; 2(4):255-7. PubMed ID: 3147914
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental study on the immunotherapy for the Pseudomonas keratitis in rabbits (author's transl)].
    Tanaka N; Ohzeki T; Tanaka I; Kinoshita N
    Nippon Ganka Gakkai Zasshi; 1977 Sep; 81(9):1252-9. PubMed ID: 415535
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis.
    Van Wye JE; Collins MS; Baylor M; Pennington JE; Hsu YP; Sampanvejsopa V; Moss RB
    Pediatr Pulmonol; 1990; 9(1):7-18. PubMed ID: 1697059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. Vaccination with lipopolysaccharide endotoxins and proteases.
    Kreger AS; Lyerly DM; Hazlett LD; Berk RS
    Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):932-9. PubMed ID: 3519522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
    Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
    Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
    Neely AN; Holder IA
    Antibiot Chemother (1971); 1987; 39():26-40. PubMed ID: 3118788
    [No Abstract]   [Full Text] [Related]  

  • 11. Feasibility of prophylaxis and therapy against gram-negative infections by human monoclonal antibodies.
    Lang AB; Fürer E; Cryz SJ
    FEMS Immunol Med Microbiol; 1993 Jun; 7(1):9-13. PubMed ID: 8364527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protective effect of Pseudomonas-specific immunoglobulin from the rabbit and of active immunization in experimental Pseudomonas sepsis in mice].
    Trautmann M; Brückner O; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):370-83. PubMed ID: 6215803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa. Vaccines and immunotherapy.
    Pennington JE
    Infect Dis Clin North Am; 1990 Jun; 4(2):259-70. PubMed ID: 2111838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
    Kinoshita M; Kato H; Yasumoto H; Shimizu M; Hamaoka S; Naito Y; Akiyama K; Moriyama K; Sawa T
    Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram-negative bacterial sepsis in burned mice.
    Fomsgaard A; Holder IA
    APMIS; 1993 Mar; 101(3):229-34. PubMed ID: 8507460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.
    Fernandes M; Vira D; Medikonda R; Kumar N
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):315-22. PubMed ID: 26537122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of collagen corneal shields in the treatment of bacterial keratitis.
    Sawusch MR; O'Brien TP; Dick JD; Gottsch JD
    Am J Ophthalmol; 1988 Sep; 106(3):279-81. PubMed ID: 3138912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation induced gram negative bacteremia and endotoxemia in rabbits: modification by anti-lipopolysaccharide hyperimmune equine plasma.
    Wells MT; Gaffin SL; Jordaan JP
    Life Sci; 1987 Jun; 40(26):2543-50. PubMed ID: 3298907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
    Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
    Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.